ArticleMedical science monitor : international medical journal of experimental and clinical research2026
Efficacy of Mouthwashes Delivered via Dental Unit Waterlines in Reducing Aerosolized Surrogate SARS-CoV-2.
Article in Medical science monitor : international medical journal of experimental and clinical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Preoperative mouthwashes are recommended to reduce viral transmission during aerosol-generating procedures (AGP) in dental settings. However, their effectiveness may be compromised due to dilution by continuous water flow from dental unit waterlines (DUWL). This study evaluated the virucidal efficacy of various mouthwashes when delivered through DUWL using a novel 3D-printed dental aerosol model, with human coronavirus OC43 (hCoV-OC43) as a surrogate for SARS-CoV-2. MATERIAL AND METHODS Five mouthwashes - 0.12% chlorhexidine digluconate (CHX), 0.07% cetylpyridinium chloride (CPC), 1% hydrogen peroxide (HP), 0.2% povidone-iodine (PVP-I), and Oral7® - were assessed using suspension and carrier tests at 3 exposure times (30 s, 2 min, and 5 min). Viral infectivity was measured by median tissue culture infectious dose (TCID₅₀/mL), and log reduction values (LRVs) were calculated. The most effective mouthwashes were further evaluated in a novel 3D-printed aerosol model simulating mouthwash delivery through DUWL during AGP. RESULTS All tested mouthwashes significantly reduced viral infectivity within 30 s. CPC, PVP-I, and Oral7® achieved >4 log₁₀ reductions (>99.99%) in suspension and aerosol tests. However, only PVP-I and Oral7® appeared to be non-cytotoxic to the host cells. CONCLUSIONS PVP-I and Oral7® mouthwashes, when delivered via DUWL, rapidly and effectively reduced aerosolized surrogate SARS-CoV-2 within 30 s in this study, while remaining non-cytotoxic to the host cells. These findings support their potential integration into clinical infection control protocols during AGP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.